In October, GSK raised $1.1 billion, or £885.6 million, by selling some of its shares in Haleon, reducing its stake in the consumer healthcare business to around 7.4%.

Sensodyne's brand purpose is to create an oral care future that is sensitivity‐free; we wanted to create a mobile-first digital experience that would help the brand achieve this goal. While the legacy ...

Exc. Medicines.) That is why Sensodyne wanted to show its target audience that tooth sensitivity pain, and/or experiencing bleeding gums can be overcome with Sensodyne through the power of mobile ...

GSK said the proposals "fundamentally failed" to reflect the value of the division. With a successful bid, Unilever - which owns Marmite, Dove and PG Tips - would add Sensodyne toothpaste and ...

which makes Sensodyne and Panadol, along with products from Pfizer - Advil and Viagra - into a separate company, GSK Healthcare, will allow the new GSK to focus on developing new drugs and ...

Shares in British pharmaceutical giant GSK rose after the company said it resolved a vast majority of lawsuits in the U.S. claiming its discontinued heartburn medicine Zantac caused cancer.

GSK spun off Haleon to form a new consumer healthcare ... of well-known consumer health products across oral health (e.g. Sensodyne), vitamins and supplements (e.g. Centrum), pain relief (e.g ...

GSK initially retained a 12.9% stake in Haleon ... The company continues to own well-known household brands such as Sensodyne toothpaste, Panadol and Advil pain relief medication, and Centrum ...